Dongfang Medical to Hold Temporary Shareholders' Meeting on August 28... Amendment to Articles of Association and Appointment of Inside Directors

Dongfang Medical (240550) announced on July 10 that it will hold a temporary shareholders' meeting on August 28, 2026, to deliberate on amendments to its articles of association and the appointment of new inside directors. The meeting will take place at the company's headquarters in Woncheon-eup, Boryeong-si, Chungcheongnam-do at 9:00 AM on August 28, 2026. The first agenda item involves adding 'human tissue distribution business and import-export' to the company's business objectives, citing new business initiatives as the rationale. The second item pertains to the appointment of new inside directors, with the company noting it will re-file details if significant changes occur. Voting will be based on shares held as of July 27, 2026, with the board resolution passed on July 10, 2026, involving three outside directors. As of July 10, 2026, Dongfang Medical's stock closed at 6,120 won, up 9.09% from the previous day. Recent results (December 2025) show total assets of 186.5 billion won, total liabilities of 61.2 billion won, equity of 125.3 billion won, revenue of 113.5 billion won, operating profit of 17 billion won, and net profit of 11.4 billion won. Dongfang Medical, a medical device manufacturer listed on KOSDAQ on December 26, 2014, is a key player in the Korean healthcare sector.